A mouse model of a human multiple GIST family with KIT‐Asp820Tyr mutation generated by a knock‐in strategy

Nobuhiro Nakai(Hyogo Medical University), Seiichi Hirota(Hyogo Medical University), Hiroyuki Hao(Hyogo Medical University), Mayumi Shincho(Hyogo Medical University), Takashi Ishikawa(Tokyo Medical University), Tatsuo Kanda(Niigata University), Akiko Nishitani(The University of Osaka), K Isozaki(Hyogo Medical University), Jiro Fujimoto(Harvard University), N‐N Liu(Hyogo Medical University), Toshirou Nishida(National Cancer Center)
The Journal of Pathology
December 21, 2007
10.1002/path.2296
Cited by 53

Related Papers

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
|The Lancet|2012|1.4k
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
|International Immunology|2008|480
Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma
|Hepatology|1998|338